TREATMENT OF INTERMEDIATE-OR HIGH-RISK PROSTATE CANCER BY DOSE ESCALATION WITH HIGH-DOSE 3D-CONFORMAL RADIOTHERAPY (HD-3D-CRT) OR LOW-DOSE 3D-CONFORMAL RADIOTHERAPY PLUS HDR BRACHYTHERAPY (LD-3D-CRT+HDR-B) : EARLY RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL

被引:0
|
作者
Guix, B. [1 ]
Bartrina, J. M. [1 ]
Tello, J. I. [1 ]
Sole, J. [1 ]
Quinzanos, L. [1 ]
Lacorte, T. [1 ]
Leon, F. [1 ]
Fernandez, J. [1 ]
Henriquez, I. [1 ]
Guix, I. [1 ]
Galdon, G. [1 ]
Espino, M. [1 ]
机构
[1] IMOR Fdn, Med Inst Radiotherapy & Oncol, Radiat Oncol, Prostate Canc Unit, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1240
引用
收藏
页码:S418 / S418
页数:1
相关论文
共 50 条
  • [21] High-dose external BEAM intensity-modulated radiotherapy (HD-IMRT) versus intensity-modulated radiotherapy plus HDR brachytherapy boost (LD-IMRT plus HDR-B) dose escalation for intermediate- or high-risk prostate cancer
    Guix, Ines
    Maria Bartrina, Jose
    Panichi, Marco
    Ignacio Tello, Jose
    Garcia, Ivan
    Maria Del Campo, Jose
    Quinzanos, Luis
    Maria Lacorte, Teresa
    Guix, Teresa
    Guix, Benjamin
    Guix, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [22] PHASE IIII TRIAL OF CETUXIMAB, CAPECITABINE, OXALIPLATIN AND 3D-CONFORMAL RADIOTHERAPY (3D-CRT) AS PREOPERATIVE TREATMENT IN RECTAL CANCER WITHOUT K-RAS MUTATIONS
    Troganis, N.
    Varveris, C.
    Mazonakis, M.
    Varveris, A.
    Lyraraki, E.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S267 - S267
  • [23] Radiation dose to organs at risk in craniospinal irradiation: Conventional 3D-conformal radiotherapy vs. helical tomotherapy
    Devecka, M.
    Duma, M. N.
    Kampfer, S.
    Hugo, C.
    Geinitz, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 81 - 82
  • [24] 3D-CONFORMAL EXTERNAL RADIOTHERAPY (3D-CRT) GIVEN CONCURRENTLY WITH DOCETAXEL AND CISPLATINUM AS RADICAL TREATMENT FOR PATIENTS WITH INOPERABLE HIGH RISK ADENOCARCINOMA OF THE PROSTATE. A PHASE 1111 STUDY.
    Sakarelis, P.
    Varveris, A.
    Varveris, C.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S254 - S254
  • [25] Early Results of 3D-Conformal Accelerated Partial Breast Irradiation Dose Escalation Phase II Trial at Gustave Roussy Institute
    Acevedo, C.
    Heymann, S.
    Levy, A.
    Verstraet, R.
    Delaloge, S.
    Mathieu, M. C.
    Gouy, S.
    Taghian, A. G.
    Marsiglia, H.
    Bourgier, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S240 - S240
  • [26] Tolerance and efficacy of high-dose 3D-conformal radiation therapy (CRT) in cirrhotic patients with small hepatocellular carcinomas (HCC) not suitable for curative therapies
    Merle, P
    Beziat, C
    Wautot, V
    Trepo, C
    Mornex, F
    HEPATOLOGY, 2005, 42 (04) : 394A - 395A
  • [27] Comparison of Dose Parameters and Toxicity during neoadjuvant Chemoradiotherapy with 3D-conformal Radiotherapy or VMAT in Patients with Esophageal Cancer
    Muench, S.
    Aichmeier, S.
    Hapfelmeier, A.
    Duma, M-N
    Oechsner, M.
    Feith, M.
    Combs, S. E.
    Habermehl, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 143 - 143
  • [28] Tolerance and efficacy of high-dose 3D-conformal radiation therapy (CRT) in cirrhotic patients with small hepatocellular carcinomas (HCC) not suitable for curative therapies
    Merle, P.
    Beziat, C.
    Wautot, V.
    Kubas, A.
    Khodri, M.
    Bottigioli, D.
    Trepo, C.
    Mornex, F.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S529 - S530
  • [29] Tolerance and efficacy of high-dose 3D-Conformal Radiation Therapy (CRT) in cirrhotic patients with small hepatocellular carcinomas (HCC) not suitable for curative therapies
    Mornex, F.
    Merle, P.
    Beziat, C.
    Wautot, V.
    Walter, T.
    Kubas, A.
    Khodri, M.
    Bottigioli, D.
    Trepo, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 403 - 403
  • [30] Acute toxicity of high dose hypofractionated 3D conformal radiotherapy in localised prostate cancer
    Macias Hernandez, V.
    Marcos-Pascua, P.
    Pijls-Johannesma, M.
    Modolell, I.
    Gallardo, J.
    Prats, J.
    Macias, D.
    Pardo, J.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S439 - S440